Transferrin-conjugated Docetaxel-PLGA nanoparticles for tumor targeting: Influence on MCF-7 cell cycle

Sajan Jose, Thomas A. Cinu, Rosmy Sebastian, M. H. Shoja, N. A. Aleykutty, Alessandra Durazzo, Massimo Lucarini, Antonello Santini, Eliana B. Souto

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Targeted drug delivery systems are commonly used to improve the therapeutic index of anti-cancer drugs by increasing their selectivity and reducing systemic distribution and toxicity. Ligand-conjugated nanoparticles (NPs) can be effectively applied for active chemotherapeutic targeting to overexpressed receptors of tumor cells. In this study, transferrin (Tf ) was successfully conjugated with poly-l-lactic-co-glycolic acid (PLGA) using ethylene diamine confirmed by NMR, for the loading of docetaxel trihydrate (DCT) into PLGA nanoparticles (NPs). The DCT-loaded Tf -conjugated PLGA NPs were produced by an emulsion-solvent evaporation technique, and a 32 full factorial design was used to optimize the nanoparticle formulations. The DCT-loaded Tf -conjugated PLGA NPs were characterized by FTIR spectroscopy, differential scanning calorimetry, powder X-ray diffraction (PXRD), TEM, particle size, and zeta potential analysis. In vitro release kinetics confirmed that release of DCT from the designed formulations followed a zero-order kinetics and a diffusion controlled non-Fickian release profile. The DCT-loaded Tf -conjugated PLGA NPs were evaluated in vitro in MCF-7 cells for bioactivity assessment. Cytotoxicity studies confirmed that the Tf -conjugated PLGA NPs were more active than the non-conjugated counterparts. Cell uptake studies re-confirmed the ligand-mediated active targeting of the formulated NPs. From the cell cycle analysis, the anti-cancer activity of DCT-loaded Tf -conjugated PLGA NPs was shown to occur by arresting the G2/M phase.

Original languageEnglish
Article number1905
JournalPolymers
Volume11
Issue number11
DOIs
Publication statusPublished - 01-11-2019
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Chemistry(all)
  • Polymers and Plastics

Fingerprint Dive into the research topics of 'Transferrin-conjugated Docetaxel-PLGA nanoparticles for tumor targeting: Influence on MCF-7 cell cycle'. Together they form a unique fingerprint.

  • Cite this

    Jose, S., Cinu, T. A., Sebastian, R., Shoja, M. H., Aleykutty, N. A., Durazzo, A., Lucarini, M., Santini, A., & Souto, E. B. (2019). Transferrin-conjugated Docetaxel-PLGA nanoparticles for tumor targeting: Influence on MCF-7 cell cycle. Polymers, 11(11), [1905]. https://doi.org/10.3390/polym11111905